|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.32 USD | -0.34% |
|
-2.19% | -8.50% |
| May. 16 | Transcript : Intra-Cellular Therapies, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM | |
| May. 07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
Intra-Cellular Therapies, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 144.87 million compared to USD 95.31 million a year ago. Net loss was USD 15.25 million compared to USD 44.05 million a year ago.
Basic loss per share from continuing operations was USD 0.16 compared to USD 0.46 a year ago. Diluted loss per share from continuing operations was USD 0.16 compared to USD 0.46 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.50% | 6.92B | |
| -1.64% | 90.28B | |
| -1.97% | 39.5B | |
| -15.95% | 31.71B | |
| +61.28% | 26.41B | |
| -22.86% | 14.34B | |
| -9.21% | 12.89B | |
| -11.77% | 11.8B | |
| -45.97% | 10.95B | |
| +3.30% | 8.85B |
INTRA-CELLULAR THERAPIES, INC. 
